Cochrane · systematic review · CD011442
Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD)
Levack, WMM, Poot, B, Weatherall, M, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
AirwaysAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 3 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Testosterone therapy compared with placebo for sexual dysfunction in men with chronic obstructive pulmonary disease (COPD)
Population: Men with COPD
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Sexual satisfaction for people with COPD 7‐point Likert scale. Scale from: 0 (best) to 6 (worst). Testosterone therapy vs placebo | no estimate extracted | 1 study · 24 participants | Low Downgraded: imprecision |
Sexual function International Index of Erectile Function (IIEF). Scale from: 0 to 25. Testosterone therapy vs placebo | no estimate extracted | 1 study · 24 participants | Low Downgraded: imprecision |
Adverse events (all cause) Testosterone therapy vs placebo | RR 1.07 [0.07, 15.54] | 1 study · 29 participants | Low Downgraded: imprecision |